Institutional Repository of Vilnius University
Gliukozės pagrindu pagaminti cholinesterazės inhibitoriai /
Abstract
dc:descriptionAlzheimer’s disease (AL) is one of the most common neurodegenerative diseases, account for about 80 % of dementia cases worldwide. AL symptoms consist of cognitive decline, weakened memory and noticeable personality changes. The disease is mainly associated with the dysfunction of the cholinergic system, where acetylcholine (ACh) is a primary neurotransmitter responsible for electrical impulse transmission between nerve cells. In AL acetylcholine levels drop rapidly due to excessive hydrolysis by acetylcholinesterase (AChE) and butyrylcholinesteraze (BChE). Inhibition of these enzymes remains the primary symptomatic treatment. Considering that current esterase inhibiting drugs often have many adverse effects like vomiting, heart and gastrointestinal dysfunctions, a search for new therapeutic agents remains important. it is likely that glucose based compounds may be safer due to their structural similarity to endogenous glucose and simple metabolic products. The aim of the study was to synthesize different glucose-6-esters via transesterification reaction with Candida Antarctica lipase B (CALB) and Candida rugosa lipase (CRL) enzymes and evaluate their potential inhibitory effects on cholinesterase’s. Synthesis yield was determined by combining amperometric glucose biosensor and DNS assay results and confirmed using TLC. An amperometric biosensor and a spectrophotometric assay were used to determine the compounds effectiveness to inhibit AChE and BChE. Obtained data was analyzed mathematically to find kinetic parameters (Km, and Vmax) and modeled using Lineweaver-Burk transformations to characterize the inhibition mechanism. Following this approach each inhibition was modeled after specific inhibition equation by Michaelis-Mentel modeling. Lastly a theoretical approach was taken to determine synthesized compounds permeability through the blood-brain barrier by ADME modeling and molecular docking. During transesterification 3 out of 7 glucose-6-esters were synthesized: glucose-6-acetate (61.17 %), glucose-6-propionate (73.58 %) and glucose-6-butyrate (67.48 %). TLC results confirmed that three glucose-6-esters were obtained only through synthesis with CALB enzyme. Afterwards it was found that these compounds could effectively inhibit AChE and BChE enzymes and for both cases, the inhibitor structure-activity relationship of glucose-6-esters followed the trend: Ac<<n-Pro<n-Bu. Based on the kinetic analysis, Lineweaver-Burk plots and Michaelis-Menten modeling, it was observed that AChE undergoes uncompetitive inhibition, whereas BChE exhibits a non-competitive inhibition mechanism. Lastly, theoretical ADME modeling conducted online indicated that glucose-6-esters do not exhibit a favorable passive permeability across the blood-brain barrier. However, molecular docking results allow predictions of possible active transport of these compounds through the GLUT1 transporter.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Morkūnaitė, Rugilė,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD308331160&prefLang=en_US